VBS Pharmaceuticals announces the publication of a peer-reviewed scientific article that describes a novel peptide that specifically targets and penetrates the vasculature of lungs affected by pulmonary arterial hypertension (PAH) in the current issue of the American Journal of Pathology.
Dr. Rebecca Baillie, will present a webinar in Rosa's monthly public webinar series "How to build a PhysioPD model" on June 20, 2011 at 1:00 pm EDT (GMT -5:00).
CMDBioscience, a computational biotechnology company focused on developing computational tools to enable peptide discovery announced today the release of CMDInventus, a proprietary and fully validated computational peptide discovery platform. This platform when combined with the CMD expertise is poised to revolutionize the field of novel peptide discovery.
PharmTech Inc., Libertyville, IL, has recently published the results of their annual survey of pharmaceutical industry decision makers "Serialization & Traceability 2011: Where are you now?".
Herzliya, Israel and Rehovot, Israel - Arkin Holdings and Foamix today announced that they have established a collaboration to develop and commercialize an innovative topical foam to treat patients with acne vulgaris and related disorders.
In the first of a series of new reports, a coalition of pharmaceutical industry trade organizations outlines the serious burden that chronic diseases place on patients and global health care systems.
Join industry professionals at SMi's CPD accredited POM to P - Critical Success Factors masterclass on 5th July 2011, Central London, UK. Learn how to overcome the major obstacles from making successful POM to P switches and register online today at http://www.smi-online.co.uk/2pom-p17.asp.
Alliance combines innovative exploratory study design, leading in silico drug development capabilities, and a global licensing network to increase the value of emerging company portfolios and address pipeline gaps for established drug manufacturers.
Publicis Touchpoint Solutions - a provider of multichannel message delivery solutions for the life sciences industry - announced that Doug Young, PhD was appointed Vice President of their Touchpoint Clinical Solutions center-of-excellence. Touchpoint Clinical Solutions specializes in clinical health educator programs, medical science liaison teams, and integrated adherence and retention solutions.
Diabetes PhysioPD model used to predict long-term clinical outcomes and select doses using only summary pharmacokinetic data from a competitor's short-term Phase I clinical trial.
India, UK and U.S. based drug companies such as Taj Pharmaceuticals, GlaxoSmithKline, Eli Lilly Group has set up a corporate venturing fund to support spin-out companies as peers plan novel approaches to future medical treatments.
Burkhard Schaefer, AnIML joined John Trigg, Director and Founder of phaseFour-informatics to discuss the biggest challenges and drivers in laboratory integration at the Pharma IQ's Immunogenicity event.
This June, Mikko Neimi, ITC member, will meet with European industry experts at Pharma IQ's Clinically Relevant Drug Transporters to discuss the ITC Whitepaper and the imminent FDA guidelines.
Crystal Pharmatech appoints Robert Wenslow as Vice President of Business Development. This reflects a big step for Crystal Pharmatech to be a truly global company and its ambition to be a top player in solid state research for pharmaceuticals.
This May, Joao Pedras-Vasconcelos, Visiting Associate, Therapeutic Proteins CBER from FDA will meet with European industry experts at Pharma IQ's to discuss FDA directives on Immunogenicity introduced in 2008.
Glenmark Pharmaceuticals announces GBR 401, an anti-CD19 monoclonal antibody. GBR 401 is developed completely in-house by Glenmark's Biologics Research Centre located in Switzerland.
CIS has announced that Diane Dellaratta, Billy Grimme, and Karen Chaney will assume clinical consultant positions with varying degrees of responsibility within CIS' clinical team headed by Annette Horner, senior director of global clinical compliance.
A leading online Canadian pharmacy, Universal Drug Store has expands his business by adding new 500 drugs in his inventory. They also introduced live chatting facility. This value-added service enhances customer convenience through prompt customer query resolution.
In collaboration with its clients, Lithera, MediciNova, Pfizer, Vitalea, Rosa & Co will present six posters at the 2011 American College on Pharmacometrics in San Diego, CA on April 4, 2011. The posters describe the use of drug-disease modeling in pharmaceutical development.
We are less than two months away from a must attend educational and networking event for scientific and business leaders involved in drug delivery and formulation to discuss the current challenges and new strategies to succeed in this evolving area.
Rosa & Co. LLC, announce the appointment of Sharan A. Pagano, Vice President, Scientific Alliances, responsible for worldwide sales and account development, and the opening of Rosa's new Boston, MA-area office.
Satisfied Users & 
Approved Press Releases
